Wenzhou Kangning Hospital Co., Ltd.

DB:4WK Stock Report

Market Cap: €108.0m

Wenzhou Kangning Hospital Management

Management criteria checks 4/4

Wenzhou Kangning Hospital's CEO is Lianyue Wang, appointed in Sep 2011, has a tenure of 13.33 years. total yearly compensation is CN¥658.80K, comprised of 71.1% salary and 28.9% bonuses, including company stock and options. directly owns 4.74% of the company’s shares, worth €5.12M. The average tenure of the management team and the board of directors is 3 years and 3.4 years respectively.

Key information

Lianyue Wang

Chief executive officer

CN¥658.8k

Total compensation

CEO salary percentage71.1%
CEO tenure13.3yrs
CEO ownership4.7%
Management average tenure3yrs
Board average tenure3.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Lianyue Wang's remuneration changed compared to Wenzhou Kangning Hospital's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

CN¥93m

Mar 31 2024n/an/a

CN¥89m

Dec 31 2023CN¥659kCN¥469k

CN¥86m

Sep 30 2023n/an/a

CN¥33m

Jun 30 2023n/an/a

-CN¥19m

Mar 31 2023n/an/a

-CN¥22m

Dec 31 2022CN¥683kCN¥516k

-CN¥24m

Sep 30 2022n/an/a

CN¥12m

Jun 30 2022n/an/a

CN¥48m

Mar 31 2022n/an/a

CN¥46m

Dec 31 2021CN¥489kCN¥397k

CN¥44m

Sep 30 2021n/an/a

CN¥45m

Jun 30 2021n/an/a

CN¥54m

Mar 31 2021n/an/a

CN¥55m

Dec 31 2020CN¥483kCN¥326k

CN¥56m

Sep 30 2020n/an/a

CN¥49m

Jun 30 2020n/an/a

CN¥42m

Mar 31 2020n/an/a

CN¥49m

Dec 31 2019CN¥438kCN¥325k

CN¥57m

Sep 30 2019n/an/a

CN¥74m

Jun 30 2019n/an/a

CN¥91m

Mar 31 2019n/an/a

CN¥86m

Dec 31 2018CN¥455kCN¥324k

CN¥81m

Compensation vs Market: Lianyue's total compensation ($USD90.00K) is below average for companies of similar size in the German market ($USD462.70K).

Compensation vs Earnings: Lianyue's compensation has been consistent with company performance over the past year.

CEO

Lianyue Wang (55 yo)

13.3yrs

Tenure

CN¥658,800

Compensation

Ms. Lianyue Wang serves as General Manager at Wenzhou Kangning Hospital Co., Ltd. Since September 2011 and has been its Executive Director since April 2013 were she is primarily responsible for the overall...

Leadership Team

NamePositionTenureCompensationOwnership
Weili Guan
Executive Chairman10.3yrsCN¥580.73k25.64%
€ 27.7m
Lianyue Wang
GM & Executive Director13.3yrsCN¥658.80k4.74%
€ 5.1m
Jian Wang
Vice GM10.5yrsCN¥884.56k0.21%
€ 226.4k
Jin Hui
Chief Financial Officer3yrsno datano data
Ning Xu
Chairman of Supervisory Committee2.6yrsno datano data
Wai Chiu Wong
Joint Company Secretary2.5yrsno datano data

3.0yrs

Average Tenure

53yo

Average Age

Experienced Management: 4WK's management team is considered experienced (3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Weili Guan
Executive Chairman10.3yrsCN¥580.73k25.64%
€ 27.7m
Lianyue Wang
GM & Executive Director11.8yrsCN¥658.80k4.74%
€ 5.1m
Jian Wang
Vice GM1.6yrsCN¥884.56k0.21%
€ 226.4k
Ning Xu
Chairman of Supervisory Committee2.9yrsno datano data
Tiefan Xie
Employee Representative Supervisor10.3yrsCN¥38.00kno data
Changhao Li
Non-Executive Director3.3yrsno datano data
Chengliang Qian
Independent Supervisor7.6yrsno datano data
Yongjiu Xu
Shareholder Representative Supervisor3.3yrsno datano data
Wentang Zhong
Independent Non Executive Director4.6yrsCN¥70.00kno data
Hao Qin
Non-Executive Director3.6yrsno datano data
Ling Jin
Independent Non Executive Director1.6yrsCN¥35.00kno data
Sai Keung Chan
Independent Non-Executive Director1.6yrsCN¥35.00kno data

3.4yrs

Average Tenure

48.5yo

Average Age

Experienced Board: 4WK's board of directors are considered experienced (3.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/06 07:58
End of Day Share Price 2025/01/03 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Wenzhou Kangning Hospital Co., Ltd. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ruili BianCitigroup Inc
Ying ShaoCLSA
Sze Chuen TamCore Pacific -Yamaichi International (H.K.) Limited